Recent research has illuminated the presence and role of cancer-associated fibroblasts (CAFs) in glioblastoma, a type of aggressive brain tumor previously thought to lack these supportive stromal cells. A pivotal study utilized single-cell RNA sequencing and spatial transcriptomics to identify CAFs in glioblastoma specimens, revealing that these cells exhibit distinct transcriptomic profiles characterized by the absence of copy number variations (CNVs) and high probabilities of being classified as CAFs based on the expression of specific markers. The study analyzed cells from 12 patient glioblastomas, demonstrating that CAFs can be isolated through serial trypsinization, which yielded cells with typical CAF morphology. Notably, the identification of CAFs in glioblastoma challenges the conventional understanding of the tumor microenvironment in the brain, suggesting a more complex interplay between tumor cells and stromal components than previously recognized (ref: Jain doi.org/10.1172/JCI147087/). The findings underscore the potential protumoral effects of CAFs, indicating that these cells may contribute to tumor progression and resistance to therapy, thus presenting new avenues for targeted treatment strategies in glioblastoma management.